Physician

Jeffrey George Tauth, M.D.

According to 2025 Medicare claims, Jeffrey Tauth, M.D. (NPI: 1437154036) practices cardiology in the Hot Springs, AR market, with the plurality of this provider's patient population coming from Garland, AR. This provider's primary affiliated billing organization is HOT SPRINGS HEART AND VASCULAR CORP (NPI: 1568082840; TIN: 850682766) and primary practice location at 71913-5418. Tauth is affiliated with the AdvantagePoint Health Alliance - Hot Springs, LLC (ACO ID: A5037), participating under the MSSP model.

Tauth's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,219 traditional Medicare patients, billed 14,213 HCPCS/CPT codes, and received $2,283,160 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 8,767 prescription claims across 1,151 beneficiaries totaling $709,040 in drug costs, led by Entresto (Sacubitril/Valsartan). DME data shows 24 claims. Open Payments data shows 18 records totaling $321. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,112,040 to $2,283,160. Similarly, Part D prescription costs have moved sharply higher in recent years, from $403,352 to $709,040. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,851 to $3,214.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,820	12,685	$1,112,040
2016	2,968	13,149	$1,145,133
2017	3,157	12,372	$1,005,139
2018	2,983	11,327	$943,014
2019	2,886	9,870	$679,941
2020	1,294	6,945	$544,045
2021	889	8,181	$720,758
2022	1,018	8,859	$679,062
2023	1,065	8,636	$589,762
2024	1,219	14,213	$2,283,160

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,229	11,338	$403,352
2016	1,174	10,617	$381,852
2017	1,190	9,995	$365,435
2018	1,168	9,101	$387,169
2019	1,145	7,403	$392,042
2020	996	5,715	$341,703
2021	805	5,568	$394,565
2022	910	6,407	$481,433
2023	1,027	7,421	$702,902
2024	1,151	8,767	$709,040

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	18	$2,249
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	23	$1,039
2021	N/R	33	$1,865
2022	N/R	54	$2,946
2023	N/R	45	$2,807
2024	N/R	24	$1,717

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	484	522	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	892	1,645	$57
93308	Ultrasound of heart, follow-up	564	592	$49
93325	Ultrasound of heart with color-depicted blood flow, rate and valve function	562	590	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	635	808	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	148	8,780	$167,833
Repatha Sureclick	Evolocumab	126	7,672	$149,341
Xarelto	Rivaroxaban	105	5,500	$101,235
Eliquis	Apixaban	84	3,601	$67,064
Praluent Pen	Alirocumab	29	2,044	$35,654

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$1,457
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$260

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$321	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey George Tauth, M.D.?

Tedicare shows public-source Medicare data for Jeffrey George Tauth, M.D. (NPI 1437154036), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey George Tauth, M.D. have ACO affiliation data?

Jeffrey George Tauth, M.D. is shown with ACO affiliation data for AdvantagePoint Health Alliance - Hot Springs, LLC (MSSP, ACO ID A5037).

What billing organization is linked to Jeffrey George Tauth, M.D.?

Jeffrey George Tauth, M.D. is linked to HOT SPRINGS HEART AND VASCULAR CORP (billing NPI 1568082840) in the available physician profile data.

Does Jeffrey George Tauth, M.D. have Open Payments data?

Jeffrey George Tauth, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.